Pathogens Help Diagnose Fatty Liver Disease

They characterized the gut microbiome compositions using whole-genome shotgun sequencing of DNA extracted from stool samples.

This process identified 37 species of bacteria that differentiated advanced NAFLD from the mild or moderate stage with 93.6% accuracy. The scientists then validated the finding in a second group of 16 patients with advanced NAFLD and 33 healthy volunteers who acted as controls. This time, they found that by testing the relative abundance of nine species of bacteria, seven of which were in the 37 identified previously, they could differentiate the NAFLD patients from the controls with 88% accuracy.

Karen E. Nelson, PhD, president of the J. Craig Venter Institute and a senior author of the study, said, “We believe our study sets the stage for a potential stool-based test to detect advanced liver fibrosis based simply on microbial patterns, or at least help us minimize the number of patients who have to undergo liver biopsies.” The study was published on May 2, 2017, in the journal Cell Metabolism.